The chloride channel inhibitor NS3736 prevents bone resorption in ovariectomized rats, while preserving bone formation.

被引：0
|
作者：
Karsdal, MA
Schaller, S
Henriksen, K
Sveigaard, C
Heegaard, A
Christophersen, P
Stahlhut, M
Hélix, N
Engsig, MT
Foged, N
Delaissé, J
机构：
[1] Nord Biosci, Herlev, Denmark
[2] NeuroSearch, Ballerup, Denmark
来源：
JOURNAL OF BONE AND MINERAL RESEARCH | 2003年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S350 / S350
页数：1
相关论文
共 50 条
  • [41] One Year of Abaloparatide, a Selective Activator of the PTH1 Receptor, Increased Bone Formation and Bone Mass in Osteopenic Ovariectomized Rats Without Increasing Bone Resorption
    Varela, Aurore
    Chouinard, Luc
    Lesage, Elisabeth
    Smith, Susan Y.
    Hattersley, Gary
    JOURNAL OF BONE AND MINERAL RESEARCH, 2017, 32 (01) : 24 - 33
  • [42] Orally active cathepsin K inhibitor, YD-1901, prevents bone resorption in vitro and in vivo in rats
    Son, MH
    Lim, JI
    Yang, JS
    Kim, MK
    Kwak, WY
    Kim, HD
    Park, JH
    Lee, SS
    Kim, HJ
    Shim, HJ
    Kim, SH
    Lee, CH
    Shim, JY
    Kim, NC
    Huh, Y
    Han, TD
    Chong, W
    Choi, H
    Ahn, BN
    Yang, SO
    JOURNAL OF BONE AND MINERAL RESEARCH, 2004, 19 : S276 - S276
  • [43] A vacuolar ATPase inhibitor, FR167356, prevents bone resorption in ovariectomized rat with high potency and specificity: Potential for clinical application
    Niikura, K
    Takeshita, N
    Takano, M
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 (09) : 1579 - 1588
  • [44] Systemic administration of acidic fibroblast growth factor (FGF-1) prevents bone loss and increases new bone formation in ovariectomized rats
    Dunstan, CR
    Boyce, R
    Boyce, BF
    Garrett, IR
    Izbicka, E
    Burgess, WH
    Mundy, GR
    JOURNAL OF BONE AND MINERAL RESEARCH, 1999, 14 (06) : 953 - 959
  • [45] HUMAN PARATHYROID HORMONE-(1-34) PREVENTS BONE LOSS AND AUGMENTS BONE-FORMATION IN SEXUALLY MATURE OVARIECTOMIZED RATS
    LIU, CC
    KALU, DN
    JOURNAL OF BONE AND MINERAL RESEARCH, 1990, 5 (09) : 973 - 982
  • [46] Vitamin K2 (menatetrenone) prevents bone loss by inhibiting osteoclast formation in ovariectomized rats.
    Akiyama, Y
    Hara, K
    Kobayashi, M
    Tomiuga, T
    Tajima, T
    JOURNAL OF BONE AND MINERAL RESEARCH, 1996, 11 : M679 - M679
  • [47] Pharmacological inhibition of Dock5 prevents osteolysis by affecting osteoclast podosome organization while preserving bone formation
    Vives, Virginie
    Cres, Gaelle
    Richard, Christian
    Busson, Muriel
    Ferrandez, Yann
    Planson, Anne-Gaelle
    Zeghouf, Mahel
    Cherfils, Jacqueline
    Malaval, Luc
    Blangy, Anne
    NATURE COMMUNICATIONS, 2015, 6
  • [48] 1,25-Dihydroxyvitamin D3 prevents bone loss of the secondary spongiosa in arthritic rats by an increase of bone formation and mineralization and inhibition of bone resorption
    Peter Oelzner
    Peter K Petrow
    Gunter Wolf
    Rolf Bräuer
    BMC Musculoskeletal Disorders, 15
  • [49] Pharmacological inhibition of Dock5 prevents osteolysis by affecting osteoclast podosome organization while preserving bone formation
    Virginie Vives
    Gaëlle Cres
    Christian Richard
    Muriel Busson
    Yann Ferrandez
    Anne-Gaelle Planson
    Mahel Zeghouf
    Jacqueline Cherfils
    Luc Malaval
    Anne Blangy
    Nature Communications, 6
  • [50] 1,25-Dihydroxyvitamin D3 prevents bone loss of the secondary spongiosa in arthritic rats by an increase of bone formation and mineralization and inhibition of bone resorption
    Oelzner, Peter
    Petrow, Peter K.
    Wolf, Gunter
    Braeuer, Rolf
    BMC MUSCULOSKELETAL DISORDERS, 2014, 15
12345